Advertisement

  • The Ins and Outs of Tumor Testing

    In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

    by Kate Yandell

  • From the Editor-in-Chief

    DNA Profiling Moves From Forensics to Diagnostics

    DNA profiling technologies are providing new ways to detect and monitor cancer.

    by William G. Nelson, MD, PhD

  • Is 3-D Mammography Better?

    A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.

    by Marci A. Landsmann

  • Cancer Control in the Community

    Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.

    by Marci A. Landsmann

  • Forward Look

    Breast Density Matters

    Breast cancer risk factor may be overlooked.

    by Kendall K. Morgan

  • A Focus on Pediatric Cancer Screening

    The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.

    by Garrett M. Brodeur

  • Revised Prostate Cancer Screening Guidelines Proposed

    The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.

  • Screening Gets Personal

    Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?

    by Kate Yandell

  • Forward Look

    All About Overdiagnosis

    Q&A with epidemiologist Pam Marcus on why cancer screening can have risks.

    by Sue Rochman

  • Forward Look

    Do You Know BRCA?

    Learn more about educational efforts to increase understanding of the 'breast cancer' gene.

    by Sue Rochman

Advertisement
Advertisement

From the AACR

Advertisement

Video

The Financial Toll of Cancer

Advertisement

social media

donate to the AACR

Subscribe to Cancer Today Magazine